Literature DB >> 2515175

Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results.

Y Maeda1, J Imai, H Kiyokawa, M Kanamura, S Hino.   

Abstract

In order to test the performance of particle agglutination assay (PA), 800 preselected PA-positive sera at 8 blood centers in the Kyushu area were tested in various assays. Most blood centers should improve their PA technique, since a third of the samples were PA-negative in our hands. A third of our PA high-titer sera were negative in indirect immunofluorescence and enzyme immunoassay, the results of which were consistent with each other. Western blots did not detect every positive serum. PA inhibition positivity was not consistent with PA titer. Most IgM antibody-positive sera also contained IgG antibody. PA should be used in combination with other methods before notifying the results to positive testees.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515175      PMCID: PMC5917873          DOI: 10.1111/j.1349-7006.1989.tb01625.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Adult T cell leukemia presenting with proliferative synovitis.

Authors:  A Taniguchi; Y Takenaka; Y Noda; Y Ueno; K Shichikawa; K Sato; N Miyasaka; K Nishioka
Journal:  Arthritis Rheum       Date:  1988-08

2.  [IgM anti-ATLA antibodies in HTLV-I healthy carriers and patients with adult T cell leukemia and HTLV-I associated myelopathy].

Authors:  S Kamihira; H Sohda; S Momita; S Ikeda; Y Moriuti; N Oyakawa; T Amagasaki; Y Yamada; M Ichimaru; T Nakamura
Journal:  Nihon Naika Gakkai Zasshi       Date:  1988-04

3.  T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome.

Authors:  J C Vernant; G Buisson; J Magdeleine; J De Thore; A Jouannelle; C Neisson-Vernant; N Monplaisir
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

4.  T-lymphocyte alveolitis in HTLV-I-associated myelopathy.

Authors:  M Sugimoto; H Nakashima; S Watanabe; E Uyama; F Tanaka; M Ando; S Araki; S Kawasaki
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

5.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

6.  Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro.

Authors:  M A Abbott; B J Poiesz; B C Byrne; S Kwok; J J Sninsky; G D Ehrlich
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

8.  A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.

Authors:  K Okochi; H Sato; Y Hinuma
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

9.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

10.  Mother-to-child transmission of human T-cell leukemia virus type-I.

Authors:  S Hino; K Yamaguchi; S Katamine; H Sugiyama; T Amagasaki; K Kinoshita; Y Yoshida; H Doi; Y Tsuji; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-06
View more
  8 in total

1.  Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay.

Authors:  H Miyakoshi; M Sugimoto; H Igarashi; H Honda; R Fujino; M Mizukoshi
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

2.  Comparison of immunofluorescence, particle agglutination, and enzyme immunoassays for detection of human T-cell leukemia virus type I antibody in African sera.

Authors:  M Verdier; F Denis; G Leonard; A Sangare; S Patillaud; M Prince-David; M Essex
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.

Authors:  S Hino; S Katamine; T Miyamoto; H Doi; Y Tsuji; T Yamabe; J E Kaplan; D L Rudolph; R B Lal
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis.

Authors:  D Nakayama; S Katamine; H Kanazawa; N Shibuya; K Kawase; R Moriuchi; T Miyamoto; S Hino
Journal:  Jpn J Cancer Res       Date:  1990-03

5.  Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Authors:  R Fujino; K Kawato; M Ikeda; H Miyakoshi; M Mizukoshi; J Imai
Journal:  Jpn J Cancer Res       Date:  1991-04

6.  Mortality among inhabitants of an HTLV-I endemic area in Japan.

Authors:  K Iwata; S Ito; H Saito; M Ito; M Nagatomo; T Yamasaki; S Yoshida; H Suto; K Tajima
Journal:  Jpn J Cancer Res       Date:  1994-03

7.  Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals.

Authors:  K Kawase; S Katamine; R Moriuchi; T Miyamoto; K Kubota; H Igarashi; H Doi; Y Tsuji; T Yamabe; S Hino
Journal:  Jpn J Cancer Res       Date:  1992-09

8.  Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.

Authors:  K Arisawa; M Soda; M Akahoshi; T Matsuo; E Nakashima; M Tomonaga; H Saito
Journal:  Jpn J Cancer Res       Date:  1998-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.